SYSTEM TO ASSESS THE BIOLOGICAL ACTIVITY OF CHEMOATTRACTANTS
    95.
    发明公开
    SYSTEM TO ASSESS THE BIOLOGICAL ACTIVITY OF CHEMOATTRACTANTS 审中-公开
    SYSTEM FOR评估的趋化因子生物活性的

    公开(公告)号:EP2089709A1

    公开(公告)日:2009-08-19

    申请号:EP07815162.8

    申请日:2007-10-30

    发明人: KUNGL, Andreas

    IPC分类号: G01N33/50 G01N33/569

    摘要: The present invention relates to a system for measuring the biological activity of chemoattractants comprising at least two units separated by a semipermeable carrier wherein biologically active carbohydrate structures, preferably glycosaminoglycan (GAG) structures, are immobilized on the surface of said carrier. According to the invention, this system can be used for fast and economic measurement of the degree of cell mobility and chemotactic activity.

    METHOD OF ASSAYING HYALURONIC ACID BY USING HYALURONIC ACID-BINDING PROTEIN
    97.
    发明公开
    METHOD OF ASSAYING HYALURONIC ACID BY USING HYALURONIC ACID-BINDING PROTEIN 有权
    法透明质酸的透明质酸结合蛋白测试

    公开(公告)号:EP1752767A4

    公开(公告)日:2008-10-15

    申请号:EP05739187

    申请日:2005-05-10

    摘要: It is intended to provide a method of assaying hyaluronic acid by using a support which suffers from little sedimentation of the support, is excellent in storage stability and shows such a high accuracy as being comparable with the existing reagents; and a reagent kit. Namely, a method of assaying hyaluronic acid characterized by comprising contacting hyaluronic acid in a sample with HABP to form a hyaluronic acid/HABP complex, then reacting the complex with a support carrying an anti-HABP antibody, measuring an optical change caused by an aggregate formed by the above reaction and calculating the amount of hyaluronic acid based on the measurement data; and a reagent kit for assaying hyaluronic acid which comprises a reagent containing HABP and a support carrying an anti-HABO antibody.

    Faktor Xa basiertes Heparin-Testverfahren unter Verwendung einer Heparin-modifizierenden Komponente
    100.
    发明公开
    Faktor Xa basiertes Heparin-Testverfahren unter Verwendung einer Heparin-modifizierenden Komponente 有权
    肝素肝素肝素肝素肝素肝素肝素肝素肝素肝素

    公开(公告)号:EP1752772A1

    公开(公告)日:2007-02-14

    申请号:EP06014877.2

    申请日:2006-07-18

    IPC分类号: G01N33/86

    摘要: Die vorliegende Erfindung liegt auf dem Gebiet der Gerinnungsdiagnostik und betrifft ein Verfahren zur Bestimmung der Heparinaktivität in einer Probe, wobei die Probe zunächst mit einer Heparin-modifizierenden Komponente wie zum Beispiel Heparinase, inkubiert wird und anschließend die Heparin-abhängige FXa-Inaktivierung gemessen wird.

    摘要翻译: 肝素依赖失活的混合因子Xa被量化。 在添加因子Xa之前,将样品与肝素修饰组分一起温育。 样品可以与来自肝素酶的酶或来自葡糖醛酸糖苷酶的酶或来自这些组中的一个或两个的不同酶的混合物一起温育。 包含用于执行该方法的测试工具的独立权利要求。